메뉴 건너뛰기




Volumn 27, Issue 12, 2012, Pages 2327-2331

Eculizumab therapy in a child with hemolytic uremic syndrome and CFI mutation

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT FACTOR I; CREATININE; ECULIZUMAB; HEMOGLOBIN; LACTATE DEHYDROGENASE; METRONIDAZOLE; UREA; COMPLEMENT COMPONENT C1; MONOCLONAL ANTIBODY;

EID: 84879308507     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-012-2283-9     Document Type: Article
Times cited : (33)

References (15)
  • 1
    • 79151471122 scopus 로고    scopus 로고
    • AHUS caused by complement dysregulation: New therapies on horizon
    • 20556434 10.1007/s00467-010-1556-4
    • Waters AM, Licht C (2011) aHUS caused by complement dysregulation: new therapies on horizon. Pediatr Nephrol 26:41-57
    • (2011) Pediatr Nephrol , vol.26 , pp. 41-57
    • Waters, A.M.1    Licht, C.2
  • 2
    • 33746508999 scopus 로고    scopus 로고
    • A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders
    • European Paediatric Research Group for HUS 16775594 1:STN:280: DC%2BD28vkslejtg%3D%3D
    • Besbas N, Karpman D, Landau D, Loirat C, Proesmans W, Remuzzi G, Rizzoni G, Taylor CM, Van de Kar N, Zimmerhackl LB, European Paediatric Research Group for HUS (2006) A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders. Kidney Int 70:423-431
    • (2006) Kidney Int , vol.70 , pp. 423-431
    • Besbas, N.1    Karpman, D.2    Landau, D.3    Loirat, C.4    Proesmans, W.5    Remuzzi, G.6    Rizzoni, G.7    Taylor, C.M.8    Van De Kar, N.9    Zimmerhackl, L.B.10
  • 3
    • 79960446438 scopus 로고    scopus 로고
    • Complement factor i in health and disease
    • 21529951 10.1016/j.molimm.2011.04.004 1:CAS:528:DC%2BC3MXpt1ahur0%3D
    • Nilsson SC, Sim RB, Lea SM, Fremeaux-Bacchi V, Blom AM (2011) Complement factor I in health and disease. Mol Immunol 48:1611-1620
    • (2011) Mol Immunol , vol.48 , pp. 1611-1620
    • Nilsson, S.C.1    Sim, R.B.2    Lea, S.M.3    Fremeaux-Bacchi, V.4    Blom, A.M.5
  • 4
    • 84859341542 scopus 로고    scopus 로고
    • Hemolytic uremic syndrome: New developments in pathogenesis and treatment
    • 21876803
    • Boyer O, Niaudet P (2011) Hemolytic uremic syndrome: new developments in pathogenesis and treatment. Int J Nephrol 2011:908407
    • (2011) Int J Nephrol , vol.2011 , pp. 908407
    • Boyer, O.1    Niaudet, P.2
  • 5
    • 29944440101 scopus 로고    scopus 로고
    • Hemolytic uremic syndrome associated with Entamoeba histolytica intestinal infection
    • 16222550 10.1007/s00467-005-2069-4
    • Cavagnaro F, Guzman C, Harris P (2006) Hemolytic uremic syndrome associated with Entamoeba histolytica intestinal infection. Pediatr Nephrol 21:126-128
    • (2006) Pediatr Nephrol , vol.21 , pp. 126-128
    • Cavagnaro, F.1    Guzman, C.2    Harris, P.3
  • 6
    • 77955779512 scopus 로고    scopus 로고
    • Advances in understanding the aetiology of atypical Haemolytic Uraemic Syndrome
    • 20629662 10.1111/j.1365-2141.2010.08295.x
    • Sánchez-Corral P, Melgosa M (2010) Advances in understanding the aetiology of atypical Haemolytic Uraemic Syndrome. Br J Haematol 150:529-542
    • (2010) Br J Haematol , vol.150 , pp. 529-542
    • Sánchez-Corral, P.1    Melgosa, M.2
  • 7
    • 70349673464 scopus 로고    scopus 로고
    • Hemolytic uremic syndrome due to homozygous factor H deficiency
    • 19568827 10.1007/s10157-009-0205-3 1:CAS:528:DC%2BD1MXhsVertrbJ
    • Sethi SK, Marie-Agnes DD, Thaker N, Hari P, Bagga A (2009) Hemolytic uremic syndrome due to homozygous factor H deficiency. Clin Exp Nephrol 13:526-530
    • (2009) Clin Exp Nephrol , vol.13 , pp. 526-530
    • Sethi, S.K.1    Marie-Agnes, D.D.2    Thaker, N.3    Hari, P.4    Bagga, A.5
  • 10
    • 48149105986 scopus 로고    scopus 로고
    • What's new in haemolytic uraemic syndrome?
    • 18575887 10.1007/s00431-008-0745-7
    • Johnson S, Taylor CM (2008) What's new in haemolytic uraemic syndrome? Eur J Pediatr 167:965-971
    • (2008) Eur J Pediatr , vol.167 , pp. 965-971
    • Johnson, S.1    Taylor, C.M.2
  • 12
    • 83155172386 scopus 로고    scopus 로고
    • Eculizumab in atypical hemolytic uremic syndrome: Long-term clinical course and histological findings
    • 21877169 10.1007/s00467-011-1989-4
    • Tschumi S, Gugger M, Bucher BS, Riedl M, Simonetti GD (2011) Eculizumab in atypical hemolytic uremic syndrome: long-term clinical course and histological findings. Pediatr Nephrol 26:2085-2088
    • (2011) Pediatr Nephrol , vol.26 , pp. 2085-2088
    • Tschumi, S.1    Gugger, M.2    Bucher, B.S.3    Riedl, M.4    Simonetti, G.D.5
  • 13
    • 84859798441 scopus 로고    scopus 로고
    • Eculizumab in the treatment of atypical hemolytic uremic syndrome in infants
    • 22196848 10.1053/j.ajkd.2011.11.027 1:CAS:528:DC%2BC38XlvVyntrY%3D
    • Ariceta G, Arrizabalaga B, Aguirre M, Morteruel E, Lopez-Trascasa M (2012) Eculizumab in the treatment of atypical hemolytic uremic syndrome in infants. Am J Kidney Dis 59:707-710
    • (2012) Am J Kidney Dis , vol.59 , pp. 707-710
    • Ariceta, G.1    Arrizabalaga, B.2    Aguirre, M.3    Morteruel, E.4    Lopez-Trascasa, M.5
  • 14
    • 78649513705 scopus 로고    scopus 로고
    • Eculizumab therapy in an adult with plasma exchange-refractory atypical hemolytic uremic syndrome
    • 20941783 10.1002/ajh.21862
    • Prescott HC, Wu HM, Cataland SR, Baiocchi RA (2010) Eculizumab therapy in an adult with plasma exchange-refractory atypical hemolytic uremic syndrome. Am J Hematol 85:976-977
    • (2010) Am J Hematol , vol.85 , pp. 976-977
    • Prescott, H.C.1    Wu, H.M.2    Cataland, S.R.3    Baiocchi, R.A.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.